RecallRadar

FDA Drug recall D-0184-2023

Vancomycin Hydrochloride for Injection, USP, 1.5 g/vial, Sterile powder, Single-dose Fliptop Vial, 10 vials per carton, Rx only, Distribute…

On 2023-02-01 the FDA classified a Class I recall of Vancomycin Hydrochloride for Injection, USP, 1.5 g/vial, Sterile powder, Single-dose Fliptop Vial, 10 vials per carton, Rx only, Distribute… by Pfizer, citing presence of Particulate Matter: Glass particulate matter detected in injectable.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0184-2023
ClassificationClass I
Statusterminated
Initiated2022-12-22
Published2023-02-01
Last updated2026-09-13 11:52 UTC
CompanyPfizer
DistributionUS

Product

Vancomycin Hydrochloride for Injection, USP, 1.5 g/vial, Sterile powder, Single-dose Fliptop Vial, 10 vials per carton, Rx only, Distributed by: Hospira, Inc., Lake Forest, IL 60045. NDC Vial 0409-3515-11; NDC Carton 0409-3515-01

Reason

Presence of Particulate Matter: Glass particulate matter detected in injectable.

Identifiers

ndc0409-6531-12
ndc0409-6531-02
ndc0409-6533-11
ndc0409-6533-01
ndc0409-6533-21
ndc0409-4332-11
ndc0409-4332-01
ndc0409-3515-11
ndc0409-3515-01
code_infoLot: 33045BA, EXP 1SEP2023

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0184-2023%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.